Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   angina pectoris
  

Disease ID 1354
Disease angina pectoris
Definition
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
Synonym
angina
angina (disorder)
angina pain
angina pectoris (disorder)
angina pectoris (disorder) [ambiguous]
angina pectoris [disease/finding]
angina pectoris nos
angina pectoris nos (disorder)
angina pectoris, nos
angina, cardiac
angina, nos
anginal pain
anginal syndrome
anginas
angor pectoris
ap - angina pectoris
cardiac angina
chest pain - cardiac
ischaemic chest pain
ischaemic chest pain (disorder)
ischaemic heart disease - angina
ischemic chest pain
ischemic chest pain (finding)
ischemic heart disease - angina
pain angina
pectoris angina
stenocardia
stenocardia (disorder)
stenocardias
UMLS
C0002962
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:53)
C0002965  |  unstable angina pectoris  |  14
C0002965  |  unstable angina  |  14
C0010068  |  coronary artery disease  |  12
C0020538  |  hypertension  |  10
C0004153  |  atherosclerosis  |  6
C0011847  |  diabetes  |  6
C0022116  |  ischemia  |  5
C0027051  |  myocardial infarct  |  5
C0027051  |  myocardial infarction  |  5
C0010054  |  coronary atherosclerosis  |  4
C0042373  |  vascular disease  |  4
C0151744  |  myocardial ischemia  |  3
C0007222  |  cardiovascular disease  |  3
C0022116  |  ischaemia  |  3
C0010073  |  coronary artery spasm  |  3
C0155626  |  acute myocardial infarction  |  3
C0018801  |  heart failure  |  3
C0018799  |  heart disease  |  2
C0151744  |  myocardial ischaemia  |  2
C0003850  |  arteriosclerosis  |  2
C0022658  |  nephropathy  |  2
C0042373  |  vascular diseases  |  2
C0010068  |  coronary disease  |  2
C0011849  |  diabetes mellitus  |  2
C0006267  |  bronchiectasis  |  2
C0007102  |  colon cancer  |  1
C0029408  |  osteoarthritis  |  1
C0020456  |  hyperglycemia  |  1
C0011570  |  depression  |  1
C0034150  |  purpura  |  1
C0010073  |  coronary spasm  |  1
C0040156  |  thyrotoxicosis  |  1
C1442837  |  myocardial necrosis  |  1
C0852949  |  arterial disease  |  1
C0043117  |  idiopathic thrombocytopenic purpura  |  1
C0007222  |  cardiovascular diseases  |  1
C0278553  |  recurrent colon cancer  |  1
C0151744  |  ischaemic heart disease  |  1
C1135191  |  systolic heart failure  |  1
C0018916  |  hemangioma  |  1
C0038531  |  subclavian steal syndrome  |  1
C0878544  |  cardiomyopathy  |  1
C0948265  |  metabolic syndrome  |  1
C0085278  |  antiphospholipid syndrome  |  1
C0264683  |  coronary atheroma  |  1
C0004030  |  aspergillosis  |  1
C0020542  |  pulmonary hypertension  |  1
C0040053  |  thrombus  |  1
C0002726  |  amyloidosis  |  1
C0018824  |  valvular heart disease  |  1
C0398625  |  protein c deficiency  |  1
C0040053  |  thrombosis  |  1
C0020443  |  hypercholesterolaemia  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:2)
AVP  |  551  |  CTD_human
PLAU  |  5328  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:16)
1361  |  CPB2  |  infer
1535  |  CYBA  |  infer
2243  |  FGA  |  infer
2244  |  FGB  |  infer
2811  |  GP1BA  |  infer
3675  |  ITGA3  |  infer
4314  |  MMP3  |  infer
4318  |  MMP9  |  infer
7941  |  PLA2G7  |  infer
5444  |  PON1  |  infer
6872  |  TAF1  |  infer
217  |  ALDH2  |  infer
348  |  APOE  |  infer
3383  |  ICAM1  |  infer
3569  |  IL6  |  infer
5175  |  PECAM1  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1354
Disease angina pectoris
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:37)
HP:0001677  |  Coronary artery disease  |  14
HP:0012531  |  Pain  |  10
HP:0000822  |  Hypertension  |  10
HP:0002621  |  Atherosclerosis  |  6
HP:0100749  |  Thoracic pain  |  6
HP:0001297  |  Cerebral vascular events  |  4
HP:0001658  |  Myocardial infarction  |  4
HP:0004929  |  Coronary artherosclerosis  |  4
HP:0001635  |  Congestive heart failure  |  3
HP:0002110  |  Bronchiectasis  |  2
HP:0011675  |  Arrhythmias  |  2
HP:0005110  |  Atrial fibrillation  |  2
HP:0000819  |  Diabetes mellitus  |  2
HP:0000112  |  Nephropathy  |  2
HP:0002094  |  Dyspnea  |  2
HP:0002140  |  Ischemic stroke  |  2
HP:0002634  |  Arteriosclerosis  |  2
HP:0011641  |  Coronary artery fistula  |  2
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0002625  |  Blood clot in a deep vein  |  1
HP:0005132  |  Pericardial constriction  |  1
HP:0000979  |  Purpura  |  1
HP:0002758  |  Osteoarthritis  |  1
HP:0001028  |  Strawberry mark  |  1
HP:0001974  |  Leukocytosis  |  1
HP:0003003  |  Colon cancer  |  1
HP:0004754  |  Permanent atrial fibrillation  |  1
HP:0000716  |  Depression  |  1
HP:0003074  |  High blood glucose  |  1
HP:0011673  |  Cardiac hemangioma  |  1
HP:0001662  |  Bradycardia  |  1
HP:0001268  |  Mental deterioration  |  1
HP:0002153  |  Elevated serum potassium levels  |  1
HP:0001700  |  Myocardial necrosis  |  1
HP:0005543  |  Reduced protein C activity  |  1
HP:0001638  |  Cardiomyopathy  |  1
HP:0011034  |  Amyloid disease  |  1
Disease ID 1354
Disease angina pectoris
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:22)
C0010068  |  coronary artery disease  |  12
C0020538  |  hypertension  |  10
C0030193  |  pain  |  10
C0011847  |  diabetes  |  6
C0008031  |  chest pain  |  6
C0022116  |  ischemia  |  5
C0010054  |  coronary atherosclerosis  |  4
C0037763  |  spasm  |  4
C0018801  |  heart failure  |  3
C0151744  |  myocardial ischemia  |  3
C0022116  |  ischaemia  |  3
C0856169  |  endothelial dysfunction  |  2
C0010068  |  coronary disease  |  2
C0013404  |  dyspnea  |  2
C0005750  |  stasis syndrome  |  1
C0242339  |  dyslipidemia  |  1
C0010073  |  coronary spasm  |  1
C0011570  |  depression  |  1
C0422833  |  ent symptoms  |  1
C0040053  |  thrombus  |  1
C1839611  |  n syndrome  |  1
C0542052  |  coronary insufficiency  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:0)
(Waiting for update.)
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:47)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0002962amilorideD0005842609-46-3angina pectorisMESH:D000787therapeutic8062500
C0002962amitriptylineD00063950-48-6angina pectorisMESH:D000787therapeutic9591892
C0002962amlodipineD01731188150-42-9angina pectorisMESH:D000787therapeutic10932030
C0002962atenololD00126229122-68-7angina pectorisMESH:D000787therapeutic101223
C0002962atropineD00128551-55-8angina pectorisMESH:D000787therapeutic6305298
C0002962betaxololD01578463659-18-7angina pectorisMESH:D000787therapeutic14559135
C0002962bisoprololD01729866722-44-9angina pectorisMESH:D000787therapeutic2439788
C0002962bleomycinD00176111056-06-7angina pectorisMESH:D000787marker/mechanism2456930
C0002962celecoxibD000068579-angina pectorisMESH:D000787marker/mechanism16681880
C0002962cyclophosphamideD00352050-18-0angina pectorisMESH:D000787marker/mechanism18849242
C0002962diatrizoateD003973117-96-4angina pectorisMESH:D000787marker/mechanism9408613
C0002962cisplatinD00294515663-27-1angina pectorisMESH:D000787marker/mechanism10397083
C0002962diclofenacD00400815307-86-5angina pectorisMESH:D000787marker/mechanism9220183
C0002962digoxinD00407720830-75-5angina pectorisMESH:D000787therapeutic2912410
C0002962dihydroergotamineD004087511-12-6angina pectorisMESH:D000787marker/mechanism8308831
C0002962diltiazemD00411042399-41-7angina pectorisMESH:D000787therapeutic10027656
C0002962fluorouracilD00547251-21-8angina pectorisMESH:D000787marker/mechanism12402434
C0002962leucovorinD0029551958/5/9angina pectorisMESH:D000787marker/mechanism15668828
C0002962indomethacinD00721353-86-1angina pectorisMESH:D000787marker/mechanism9220183
C0002962isradipineD01727575695-93-1angina pectorisMESH:D000787marker/mechanism11002857
C0002962isradipineD01727575695-93-1angina pectorisMESH:D000787therapeutic1703598
C0002962labetalolD00774136894-69-6angina pectorisMESH:D000787therapeutic2908732
C0002962leuprolideD01672953714-56-0angina pectorisMESH:D000787marker/mechanism8030717
C0002962metoprololD00879037350-58-6angina pectorisMESH:D000787therapeutic21112460
C0002962mifepristoneD01573584371-65-3angina pectorisMESH:D000787marker/mechanism11187221
C0002962nelfinavirD019888159989-64-7angina pectorisMESH:D000787marker/mechanism18025881
C0002962nisoldipineD01573763675-72-9angina pectorisMESH:D000787therapeutic11720635
C0002962nitric oxideD00956910102-43-9angina pectorisMESH:D000787therapeutic1686696
C0002962phenylephrineD01065659-42-7angina pectorisMESH:D000787marker/mechanism10389447
C0002962prazosinD01122419216-56-9angina pectorisMESH:D000787marker/mechanism472855
C0002962propranololD011433525-66-6angina pectorisMESH:D000787marker/mechanism12113709
C0002962propranololD011433525-66-6angina pectorisMESH:D000787therapeutic101223
C0002962epoprostenolD01146435121-78-9angina pectorisMESH:D000787therapeutic2433921
C0002962ramiprilD01725787333-19-5angina pectorisMESH:D000787therapeutic10732883
C0002962ranolazineD000069458-angina pectorisMESH:D000787therapeutic11975803
C0002962rosiglitazoneC089730-angina pectorisMESH:D000787marker/mechanism19591532
C0002962sotalolD0130153930-20-9angina pectorisMESH:D000787marker/mechanism7171401
C0002962sotalolD0130153930-20-9angina pectorisMESH:D000787therapeutic1360557
C0002962dextrothyroxineD00391851-49-0angina pectorisMESH:D000787marker/mechanism5818672
C0002962ticlopidineD01398855142-85-3angina pectorisMESH:D000787therapeutic19309387
C0002962timololD01399926839-75-8angina pectorisMESH:D000787therapeutic2508936
C0002962vinblastineD014747865-21-4angina pectorisMESH:D000787marker/mechanism2456930
C0002962vincristineD014750-angina pectorisMESH:D000787marker/mechanism11724093
C0002962vindesineD01475153643-48-4angina pectorisMESH:D000787marker/mechanism3948198
C0002962vinorelbineC03085271486-22-1angina pectorisMESH:D000787marker/mechanism10731757
C0002962vitamin eD0148101406-18-4angina pectorisMESH:D000787marker/mechanism15562867
C0002962vitamin eD0148101406-18-4angina pectorisMESH:D000787therapeutic9822095
FDA approved drug and dosage information(Total Drugs:3)
DiseaseID Drug_name active_ingredients strength Dosage Form/Route Marketing Status TE code RLD RS
MESH:D000787celebrexcelecoxib100MGCAPSULE;ORALPrescriptionABYesNo
MESH:D000787celebrexcelecoxib100MGCAPSULE;ORALPrescriptionNoneNoNo
MESH:D000787inomaxnitric oxide100PPM Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasonsGAS;INHALATIONDiscontinuedNoneYesNo
FDA labeling changes(Total Drugs:3)
DiseaseID Pediatric_Labeling_Date Trade_Name Generic_Name_or_Proper_Name Indications Studied Label Changes Summary Product Labeling BPCA(B) PREA(P) BPCA(B) and PREA(P) Pediatric Rule (R) Sponsor Pediatric Exclusivity Granted Date NNPS
MESH:D00078712/15/2006celebrexcelecoxibRelief of the signs and symptoms of juvenile rheumatoid arthritis (JRA)New indication in 2 years and older Has not been studied in patients < 2 years, in patients with body weight < 10 kg, or in patients with active systemic features Celecoxib should be used only with caution in patients with systemic onset JRA due to the risk for serious adverse reactions including the risk of disseminated intravascular coagulation The long-term cardiovascular toxicity in children has not been evaluated; it is unknown if the long-term risk may be similar to that seen in adults New 50 mg capsule developed Information on adding contents of a capsule to applesauce. for patients with difficulty swallowing capsules Information on dose, clinical studies, PK parameters, AEsLabelingB---Pfizer08/23/2006FALSE'
MESH:D00078712/15/2006celebrexcelecoxibRelief of the signs and symptoms of juvenile rheumatoid arthritis (JRA)New indication in 2 years and older Has not been studied in patients < 2 years, in patients with body weight < 10 kg, or in patients with active systemic features Celecoxib should be used only with caution in patients with systemic onset JRA due to the risk for serious adverse reactions including the risk of disseminated intravascular coagulation The long-term cardiovascular toxicity in children has not been evaluated; it is unknown if the long-term risk may be similar to that seen in adults New 50 mg capsule developed Information on adding contents of a capsule to applesauce. for patients with difficulty swallowing capsules Information on dose, clinical studies, PK parameters, AEsLabelingB---Pfizer08/23/2006FALSE'
MESH:D00078712/21/2010inomaxnitric oxidePrevention of bronchopulmonary dysplasiaINOmax is not indicated for prevention of BPD in preterm neonates d 34 weeks gestational age.Efficacy for the prevention of BPD in preterm infants was not established in three ldouble-blind, placebo-controlled clinical trials in a total of 2,149 preterm infants Information on clinical trials, adverse reactionLabelingB---INO Therapeutics2/11/2010FALSE'